Kane Biotech Announces Fourth Quarter and Full Year 2021 Fin

24.03.2022 - WINNIPEG, Manitoba, March 24, 2022 (GLOBE NEWSWIRE) - Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced its fourth quarter and full year 2021 financial results. Fourth Quarter Financial Highlights ...

Related Keywords

United States , Canada , America , Canadian , Nicole Sendey , Kane Derma , Ray Dupuis , Marc Edwards , Kevin Cole , Participant International Dial , European Patent Office , Financial Inc , Animal Health Inc , Kane Biotech Inc , Dow Development Laboratories , Canadian Dermatology Association Expert Advisory Board , Animal Health , Venture Exchange , Regulation Services Provider , Company Dispersin , Dechra Veterinary Products , Skin Health Program , Total Revenue , Year Financial , Manufacturing Practices , Petsmart Canada , South America , Pivot Financial , Kane Biotech , Management Discussion , Toll Free Dial In Number , International Dial In Number ,